The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAGIO THERAPEUTICS INC | COM | 00534A102 | 508 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 36,949 | 3,112,785 | SH | SOLE | 3,112,785 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,935 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 15,512 | 1,120,000 | SH | SOLE | 1,120,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 62,458 | 2,906,352 | SH | SOLE | 2,906,352 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 7,219 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 47,280 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 5,185 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 21,249 | 1,630,744 | SH | SOLE | 1,630,744 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 52,957 | 870,000 | SH | SOLE | 870,000 | 0 | 0 | ||
BIOMEA FUSION INC | COM | 09077A106 | 1,879 | 252,320 | SH | SOLE | 252,320 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 5,118 | 454,545 | SH | SOLE | 454,545 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 9,739 | 614,095 | SH | SOLE | 614,095 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 1,287 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 6,630 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 4,450 | 288,458 | SH | SOLE | 288,458 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 60,394 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 624 | 37,069 | SH | SOLE | 37,069 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 59,359 | 2,772,501 | SH | SOLE | 2,772,501 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 42,122 | 1,664,251 | SH | SOLE | 1,664,251 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 38,457 | 3,234,392 | SH | SOLE | 3,234,392 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 12,988 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
ELEDON PHARMACEUTICALS INC | COM | 28617K101 | 5,908 | 1,339,793 | SH | SOLE | 1,339,793 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 12,283 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 5,500 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 22,752 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 12,118 | 685,000 | SH | SOLE | 685,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 21,953 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 5,050 | 406,308 | SH | SOLE | 406,308 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 14,572 | 1,930,000 | SH | SOLE | 1,930,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 36,642 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 3,760 | 299,853 | SH | SOLE | 299,853 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 21,736 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 3,653 | 185,196 | SH | SOLE | 185,196 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 11,273 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 39,300 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 24,244 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 12,698 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LANDOS BIOPHARMA INC | COM | 515069102 | 6,600 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 2,543 | 412,837 | SH | SOLE | 412,837 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,544 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 75 | 46,984 | SH | SOLE | 46,984 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 7,335 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 8,412 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 2,563 | 134,650 | SH | SOLE | 134,650 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 126 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 35,043 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
OMEGA THERAPEUTICS INC | COMMON STOCK | 68217N105 | 999 | 88,235 | SH | SOLE | 88,235 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,550 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 3,144 | 286,652 | SH | SOLE | 286,652 | 0 | 0 | ||
RAIN THERAPEUTICS INC | COM | 75082Q105 | 3,158 | 245,161 | SH | SOLE | 245,161 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 9,012 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 35,853 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 2,333 | 200,493 | SH | SOLE | 200,493 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 4,906 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 5,031 | 329,013 | SH | SOLE | 329,013 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 3,104 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 6,660 | 473,394 | SH | SOLE | 473,394 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 36,230 | 1,824,280 | SH | SOLE | 1,824,280 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 1,336 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 820 | 122,000 | SH | SOLE | 122,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 16,343 | 443,265 | SH | SOLE | 443,265 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 3,900 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 2,512 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 4,053 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 5,688 | 350,000 | SH | SOLE | 350,000 | 0 | 0 |